$GNLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENELABS TECHNOLOGIES INC /CA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENELABS TECHNOLOGIES INC /CA. Get notifications about new insider transactions in GENELABS TECHNOLOGIES INC /CA for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2009 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.30 | 5,374,343 | 6,986,646 | 0 | 5.4 M to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | CHAIRMAN OF THE BOA ... | Sell | U | 1.30 | 9,056 | 11,773 | 0 | 9.1 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | CHAIRMAN OF THE BOA ... | Sell | U | 1.30 | 33,125 | 43,063 | 9,056 | 42.2 K to 9.1 K (-78.53 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Sell | U | 1.30 | 43,000 | 55,900 | 0 | 43 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Sell | U | 1.30 | 9,000 | 11,700 | 43,000 | 52 K to 43 K (-17.31 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Sell | U | 1.30 | 900 | 1,170 | 0 | 900 to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | GRIFFITH RONALD C | Chief Scientific Of ... | Sell | U | 1.30 | 992 | 1,290 | 0 | 992 to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CEO/PRESIDENT | Sell | U | 1.30 | 15,298 | 19,887 | 0 | 15.3 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CEO/PRESIDENT | Sell | U | 1.30 | 6,890 | 8,957 | 15,298 | 22.2 K to 15.3 K (-31.05 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP, BUSINESS DEVELO ... | Sell | U | 1.30 | 18,166 | 23,616 | 0 | 18.2 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP, BUSINESS DEVELO ... | Sell | U | 1.30 | 12,708 | 16,520 | 18,166 | 30.9 K to 18.2 K (-41.16 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | WEBB DANIEL CLINTON | Director, Legal/Cor ... | Sell | U | 1.30 | 14,875 | 19,338 | 0 | 14.9 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | PFEFFER MATTHEW J | Director | Sell | P | 1.30 | 10,000 | 13,000 | 0 | 10 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Sell | J | 1.30 | 10,000 | 13,000 | 0 | 10 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Sell | J | 1.30 | 10,000 | 13,000 | 0 | 10 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CEO | Sell | J | 1.30 | 230,000 | 299,000 | 0 | 230 K to 0 (-100.00 %) |
Jan 07 2009 | GNLB | GENELABS TECHNOLOG ... | Browne Leslie J | Director | Sell | J | 1.30 | 10,000 | 13,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.28 | 300 | 384 | 5,374,343 | 5.4 M to 5.4 M (+0.01 %) |
Dec 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.28 | 3,300 | 4,224 | 5,374,043 | 5.4 M to 5.4 M (+0.06 %) |
Dec 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.28 | 3,300 | 4,224 | 5,370,743 | 5.4 M to 5.4 M (-0.06 %) |
Nov 10 2008 | GNLB | GENELABS TECHNOLOG ... | WEBB DANIEL CLINTON | Director, Legal/Cor ... | Buy | J | 0.54 | 6,225 | 3,333 | 6,225 | 0 to 6.2 K |
Nov 10 2008 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP, BUSINESS DEVELO ... | Buy | J | 0.54 | 3,431 | 1,837 | 30,874 | 27.4 K to 30.9 K (+12.50 %) |
Nov 06 2008 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CEO/PRESIDENT | Buy | J | 0.54 | 15,298 | 8,192 | 22,188 | 6.9 K to 22.2 K (+222.03 %) |
Oct 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.43 | 35,600 | 15,308 | 5,374,543 | 5.4 M to 5.4 M (-0.66 %) |
Oct 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.43 | 35,600 | 15,308 | 5,410,143 | 5.4 M to 5.4 M (+0.66 %) |
Oct 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.43 | 1,300 | 559 | 5,374,543 | 5.4 M to 5.4 M (+0.02 %) |
Nov 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.23 | 8,200 | 10,086 | 5,374,043 | 5.4 M to 5.4 M (+0.15 %) |
Nov 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.23 | 8,200 | 10,086 | 5,365,843 | 5.4 M to 5.4 M (-0.15 %) |
Nov 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.24 | 500 | 620 | 5,374,043 | 5.4 M to 5.4 M (-0.01 %) |
Sep 04 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.46 | 8,500 | 3,910 | 5,373,243 | 5.4 M to 5.4 M (-0.16 %) |
Sep 04 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.48 | 3,600 | 1,728 | 5,381,743 | 5.4 M to 5.4 M (-0.07 %) |
Sep 04 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.46 | 8,500 | 3,910 | 5,385,343 | 5.4 M to 5.4 M (+0.16 %) |
Sep 03 2008 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CEO/PRESIDENT | Option Exercise | A | 0.48 | 75,334 | 36,160 | 75,334 | |
Sep 03 2008 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CEO/PRESIDENT | Option Exercise | A | 0.48 | 154,666 | 74,240 | 154,666 | |
Aug 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.50 | 46,700 | 23,350 | 5,376,843 | 5.4 M to 5.4 M (-0.86 %) |
Aug 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.50 | 46,700 | 23,350 | 5,423,543 | 5.4 M to 5.4 M (+0.87 %) |
Jul 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.60 | 3,100 | 1,860 | 5,376,843 | 5.4 M to 5.4 M (-0.06 %) |
Jul 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.62 | 51,800 | 32,116 | 5,379,943 | 5.4 M to 5.4 M (-0.95 %) |
Jul 03 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.62 | 51,800 | 32,116 | 5,431,743 | 5.4 M to 5.4 M (+0.96 %) |
Jul 02 2008 | GNLB | GENELABS TECHNOLOG ... | PFEFFER MATTHEW J | Director | Option Exercise | A | 0.63 | 10,000 | 6,300 | 10,000 | |
Jul 02 2008 | GNLB | GENELABS TECHNOLOG ... | Browne Leslie J | Director | Option Exercise | A | 0.63 | 10,000 | 6,300 | 10,000 | |
Jul 02 2008 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Option Exercise | A | 0.63 | 10,000 | 6,300 | 10,000 | |
Jul 02 2008 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Option Exercise | A | 0.63 | 10,000 | 6,300 | 10,000 | |
Jun 30 2008 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP BUSINESS DEVELOP ... | Buy | J | 0.58 | 7,923 | 4,579 | 27,443 | 19.5 K to 27.4 K (+40.59 %) |
Jun 30 2008 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | VP, BUSINESS STRAT ... | Buy | J | 0.58 | 19,685 | 11,378 | 67,903 | 48.2 K to 67.9 K (+40.83 %) |
Jun 30 2008 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | CHAIRMAN OF THE BOA ... | Buy | J | 0.58 | 19,685 | 11,378 | 49,479 | 29.8 K to 49.5 K (+66.07 %) |
Jun 04 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.91 | 35,700 | 32,487 | 5,379,943 | 5.4 M to 5.4 M (-0.66 %) |
Jun 04 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.91 | 35,700 | 32,487 | 5,415,643 | 5.4 M to 5.4 M (+0.66 %) |
Apr 09 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.79 | 59,113 | 46,699 | 5,384,943 | 5.4 M to 5.4 M (-1.09 %) |
Apr 09 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.93 | 4,787 | 4,452 | 5,444,056 | 5.4 M to 5.4 M (-0.09 %) |
May 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.88 | 5,000 | 4,400 | 5,379,943 | 5.4 M to 5.4 M (-0.09 %) |
May 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.91 | 95,100 | 86,541 | 5,384,943 | 5.5 M to 5.4 M (-1.74 %) |
May 05 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 0.91 | 95,100 | 86,541 | 5,480,043 | 5.4 M to 5.5 M (+1.77 %) |
Apr 04 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 0.90 | 3,200 | 2,880 | 5,448,843 | 5.5 M to 5.4 M (-0.06 %) |
Mar 06 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.12 | 600 | 672 | 5,452,043 | 5.5 M to 5.5 M (-0.01 %) |
Mar 06 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.13 | 4,399 | 4,971 | 5,452,643 | 5.5 M to 5.5 M (-0.08 %) |
Mar 06 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.14 | 262,100 | 298,794 | 5,457,042 | 5.7 M to 5.5 M (-4.58 %) |
Mar 06 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 1.14 | 262,100 | 298,794 | 5,719,142 | 5.5 M to 5.7 M (+4.80 %) |
Mar 06 2008 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Sell | S | 1.10 | 5,101 | 5,611 | 5,457,042 | 5.5 M to 5.5 M (-0.09 %) |
Feb 13 2008 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | VP, BUSINESS STRAT ... | Option Exercise | A | 1.31 | 20,000 | 26,200 | 20,000 | |
Feb 13 2008 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP BUSINESS DEVELOP ... | Option Exercise | A | 1.31 | 20,000 | 26,200 | 20,000 | |
Feb 13 2008 | GNLB | GENELABS TECHNOLOG ... | GRIFFITH RONALD C | V.P. RESEARCH | Option Exercise | A | 1.31 | 33,500 | 43,885 | 33,500 | |
Feb 13 2008 | GNLB | GENELABS TECHNOLOG ... | SCHWARTZ KENNETH E | V.P. Medical Affair ... | Option Exercise | A | 1.31 | 20,000 | 26,200 | 20,000 | |
Feb 13 2008 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | CHAIRMAN OF THE BOA ... | Option Exercise | A | 1.31 | 16,051 | 21,027 | 16,051 | |
Feb 13 2008 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | CHAIRMAN OF THE BOA ... | Option Exercise | A | 1.31 | 17,449 | 22,858 | 17,449 | |
Dec 28 2007 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP BUSINESS DEVELOP ... | Buy | J | 1.11 | 2,398 | 2,650 | 19,520 | 17.1 K to 19.5 K (+14.01 %) |
Dec 28 2007 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | PRESIDENT & CEO | Buy | J | 1.11 | 4,552 | 5,030 | 48,157 | 43.6 K to 48.2 K (+10.44 %) |
Dec 28 2007 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | VP, BUSINESS STRAT ... | Buy | J | 1.11 | 3,856 | 4,261 | 48,218 | 44.4 K to 48.2 K (+8.69 %) |
Dec 28 2007 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | CHAIRMAN OF THE BOA ... | Buy | J | 1.11 | 7,918 | 8,749 | 29,794 | 21.9 K to 29.8 K (+36.19 %) |
Nov 28 2007 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CFO | Buy | P | 1.45 | 6,890 | 9,991 | 6,890 | 0 to 6.9 K |
Nov 19 2007 | GNLB | GENELABS TECHNOLOG ... | DRISCOLL FREDERICK W | CFO | Option Exercise | A | 1.69 | 200,000 | 338,000 | 200,000 | |
Nov 07 2007 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 2.00 | 82,068 | 164,136 | 5,462,134 | 5.4 M to 5.5 M (+1.53 %) |
Nov 07 2007 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 2.02 | 100,000 | 202,000 | 5,380,075 | 5.3 M to 5.4 M (+1.89 %) |
Nov 07 2007 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 2.05 | 50,000 | 102,500 | 5,280,075 | 5.2 M to 5.3 M (+0.96 %) |
Nov 07 2007 | GNLB | GENELABS TECHNOLOG ... | MORGAN STANLEY | 10% Owner | Buy | P | 2.00 | 732 | 1,464 | 5,230,075 | 5.2 M to 5.2 M (+0.01 %) |
Aug 01 2007 | GNLB | GENELABS TECHNOLOG ... | GRIFFITH RONALD C | Chief Scientific Of ... | Option Exercise | A | 1.96 | 33,500 | 65,660 | 100,833 | |
Aug 01 2007 | GNLB | GENELABS TECHNOLOG ... | GRIFFITH RONALD C | Chief Scientific Of ... | Option Exercise | A | 1.96 | 67,333 | 131,973 | 67,333 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | Browne Leslie J | Director | Option Exercise | A | 1.96 | 20,000 | 39,200 | 20,000 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Option Exercise | A | 1.96 | 10,000 | 19,600 | 10,000 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President and CEO | Option Exercise | A | 1.96 | 76,901 | 150,726 | 110,401 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President and CEO | Option Exercise | A | 1.96 | 33,500 | 65,660 | 33,500 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | SCHWARTZ KENNETH E | vp Medical Affairs | Option Exercise | A | 1.96 | 20,000 | 39,200 | 58,649 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | SCHWARTZ KENNETH E | vp Medical Affairs | Option Exercise | A | 1.96 | 38,649 | 75,752 | 38,649 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | vp business develop ... | Option Exercise | A | 1.96 | 20,000 | 39,200 | 82,395 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | vp business develop ... | Option Exercise | A | 1.96 | 62,395 | 122,294 | 62,395 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | VP Business Strateg ... | Option Exercise | A | 1.96 | 20,000 | 39,200 | 76,899 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | VP Business Strateg ... | Option Exercise | A | 1.96 | 56,899 | 111,522 | 56,899 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Option Exercise | A | 1.96 | 33,500 | 65,660 | 176,654 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Option Exercise | A | 1.96 | 143,154 | 280,582 | 143,154 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Option Exercise | A | 1.96 | 10,000 | 19,600 | 10,000 | |
Jul 31 2007 | GNLB | GENELABS TECHNOLOG ... | PFEFFER MATTHEW J | Director | Option Exercise | A | 1.96 | 20,000 | 39,200 | 20,000 | |
Jul 02 2007 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President & CEO | Buy | J | 1.24 | 12,571 | 15,601 | 43,605 | 31 K to 43.6 K (+40.51 %) |
Jul 02 2007 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP Business Develop ... | Buy | J | 1.24 | 3,273 | 4,062 | 17,122 | 13.8 K to 17.1 K (+23.63 %) |
Jul 02 2007 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | VP Business Strateg ... | Buy | J | 1.24 | 13,267 | 16,464 | 44,362 | 31.1 K to 44.4 K (+42.67 %) |
Jul 02 2007 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Buy | J | 1.24 | 3,022 | 3,750 | 14,578 | 11.6 K to 14.6 K (+26.15 %) |
Jan 03 2007 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President & CEO | Buy | J | 1.21 | 6,928 | 8,362 | 31,034 | 24.1 K to 31 K (+28.74 %) |
Jan 03 2007 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | VP, Business Strate ... | Buy | J | 1.21 | 3,706 | 4,473 | 31,095 | 27.4 K to 31.1 K (+13.53 %) |
Jan 03 2007 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP, Business Develo ... | Buy | J | 1.21 | 2,071 | 2,500 | 13,849 | 11.8 K to 13.8 K (+17.58 %) |
Jan 03 2007 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | chairman of the Boa ... | Buy | J | 1.21 | 870 | 1,050 | 11,556 | 10.7 K to 11.6 K (+8.14 %) |
Jun 30 2006 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President and CEO | Buy | J | 1.17 | 2,414 | 2,832 | 24,106 | 21.7 K to 24.1 K (+11.13 %) |
Jun 30 2006 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP, Business Develo ... | Buy | J | 1.17 | 3,107 | 3,645 | 11,778 | 8.7 K to 11.8 K (+35.83 %) |
Jun 30 2006 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Buy | J | 1.17 | 888 | 1,042 | 10,686 | 9.8 K to 10.7 K (+9.06 %) |
Jun 30 2006 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | Bus. Strategy Adv. ... | Buy | J | 1.17 | 5,030 | 5,900 | 27,389 | 22.4 K to 27.4 K (+22.50 %) |
Jun 16 2006 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Option Exercise | A | 1.67 | 1,000 | 1,670 | 4,000 | |
Jun 16 2006 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Option Exercise | A | 1.67 | 3,000 | 5,010 | 3,000 | |
Jun 16 2006 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Option Exercise | A | 1.67 | 1,000 | 1,670 | 4,000 | |
Jun 16 2006 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Option Exercise | A | 1.67 | 3,000 | 5,010 | 3,000 | |
Jun 16 2006 | GNLB | GENELABS TECHNOLOG ... | GRAY ARTHUR JR | Director | Option Exercise | A | 1.67 | 1,000 | 1,670 | 4,000 | |
Jun 16 2006 | GNLB | GENELABS TECHNOLOG ... | GRAY ARTHUR JR | Director | Option Exercise | A | 1.67 | 3,000 | 5,010 | 3,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President and CEO | Option Exercise | F | 1.91 | 33,000 | 63,030 | 33,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | SCHWARTZ KENNETH E | VP,Medical Affairs | Option Exercise | A | 1.91 | 20,000 | 38,200 | 20,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | GRIFFITH RONALD C | VP, Research | Option Exercise | A | 1.91 | 33,000 | 63,030 | 33,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | LOAR MATTHEW M | CFO | Option Exercise | A | 1.91 | 33,000 | 63,030 | 33,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP, Business Develo ... | Option Exercise | A | 1.91 | 20,000 | 38,200 | 20,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | Sr. Bus.Strategy Ad ... | Option Exercise | A | 1.91 | 20,000 | 38,200 | 20,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Option Exercise | A | 1.91 | 33,000 | 63,030 | 33,000 | |
Jan 31 2006 | GNLB | GENELABS TECHNOLOG ... | ARIMA ADRIAN | VP, General counsel | Option Exercise | A | 1.91 | 20,000 | 38,200 | 20,000 | |
Jan 03 2006 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President and CEO | Buy | J | 1.58 | 1 | 2 | 21,692 | 21.7 K to 21.7 K (0.00 %) |
Jan 03 2006 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP Business Develop ... | Buy | J | 1.58 | 1,518 | 2,400 | 8,671 | 7.2 K to 8.7 K (+21.22 %) |
Jan 03 2006 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | Sr. Bus. Strategy A ... | Buy | J | 1.58 | 2,079 | 3,287 | 22,359 | 20.3 K to 22.4 K (+10.25 %) |
Jan 03 2006 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Buy | J | 1.58 | 632 | 999 | 9,798 | 9.2 K to 9.8 K (+6.90 %) |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | AHMED MUMTAZ | VP Drug Development | Option Exercise | A | 0.47 | 100,000 | 47,000 | 100,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President & CEO | Option Exercise | A | 0.47 | 200,000 | 94,000 | 200,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | SCHWARTZ KENNETH E | VP Medical Affairs | Option Exercise | A | 0.47 | 100,000 | 47,000 | 100,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | LOAR MATTHEW M | CFO | Option Exercise | A | 0.47 | 100,000 | 47,000 | 100,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | GRIFFITH RONALD C | VP Research | Option Exercise | A | 0.47 | 100,000 | 47,000 | 100,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | Sr. Bus. Strategy A ... | Option Exercise | A | 0.47 | 100,000 | 47,000 | 100,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | VP Business Develop ... | Option Exercise | A | 0.47 | 100,000 | 47,000 | 100,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | ARIMA ADRIAN | V.P. General Counse ... | Option Exercise | A | 0.47 | 100,000 | 47,000 | 100,000 | |
Dec 07 2005 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Option Exercise | A | 0.47 | 200,000 | 94,000 | 200,000 | |
Jun 30 2005 | GNLB | GENELABS TECHNOLOG ... | SMITH JAMES ANGUS DUNCAN | President & CEO | Buy | J | 0.45 | 20,833 | 9,375 | 108,459 | 87.6 K to 108.5 K (+23.77 %) |
Jun 30 2005 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | Sr. Bus. Strategy A ... | Buy | J | 0.45 | 14,602 | 6,571 | 101,406 | 86.8 K to 101.4 K (+16.82 %) |
Jun 30 2005 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | V.P. Business Devel ... | Buy | J | 0.45 | 7,817 | 3,518 | 35,768 | 28 K to 35.8 K (+27.97 %) |
Jun 14 2005 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Option Exercise | A | 0.44 | 5,000 | 2,200 | 20,000 | |
Jun 14 2005 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jun 14 2005 | GNLB | GENELABS TECHNOLOG ... | GRAY ARTHUR JR | Director | Option Exercise | A | 0.44 | 5,000 | 2,200 | 20,000 | |
Jun 14 2005 | GNLB | GENELABS TECHNOLOG ... | GRAY ARTHUR JR | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jun 14 2005 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Option Exercise | A | 0.44 | 5,000 | 2,200 | 20,000 | |
Jun 14 2005 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | ARIMA ADRIAN | V.P., General Couns ... | Option Exercise | A | 0.88 | 30,000 | 26,400 | 45,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | ARIMA ADRIAN | V.P., General Couns ... | Option Exercise | A | 0.88 | 15,000 | 13,200 | 15,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | CHOW IRENE A | Director | Option Exercise | A | 0.88 | 80,000 | 70,400 | 80,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | HAIGHT HENRY H IV | Director | Option Exercise | A | 0.88 | 30,000 | 26,400 | 30,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | KWAN ALAN Y | Director | Option Exercise | A | 0.88 | 30,000 | 26,400 | 30,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | GRAY ARTHUR JR | Director | Option Exercise | A | 0.88 | 30,000 | 26,400 | 30,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | V.P. Business Devel ... | Option Exercise | A | 0.88 | 50,000 | 44,000 | 80,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | WU ROY J | V.P. Business Devel ... | Option Exercise | A | 0.88 | 30,000 | 26,400 | 30,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | SCHWARTZ KENNETH E | V.P. Medical Affair ... | Option Exercise | A | 0.88 | 30,000 | 26,400 | 60,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | SCHWARTZ KENNETH E | V.P. Medical Affair ... | Option Exercise | A | 0.88 | 30,000 | 26,400 | 30,000 | |
Jan 31 2005 | GNLB | GENELABS TECHNOLOG ... | KELLER HEATHER | Sr.Bus. Strategy Ad ... | Option Exercise | A | 0.88 | 20,000 | 17,600 | 50,000 |